Malhone Carolina, Longatto-Filho Adhemar, Filassi José Roberto
Breast Division, Cancer Institute of São Paulo, University of São Paulo School of Medicine, São Paulo, Brazil.
Laboratory of Medical Investigation (LIM) 14, Department of Pathology, University of São Paulo School of Medicine, São Paulo, Brazil.
Acta Cytol. 2018;62(3):166-177. doi: 10.1159/000487700. Epub 2018 Apr 25.
Although the association of human papillomavirus (HPV) with many cancers is well established, the involvement of HPV in breast cancer remains controversial. The purpose of this study is to perform a comprehensive review of the results and methods used to demonstrate that HPV markers are present in human breast cancer, and how well these studies fulfil the criteria for proving the viral etiology of a cancer.
We conducted a search for molecular studies published until November 2016 that relate human breast cancer to HPV.
Forty-three original molecular studies were found, some of which compared cases to nonneoplastic controls. Some investigations did not identify HPV in mammary tissue, but others identified it with different frequencies of positivity, varying between 1.2 and 86%. In most case-control studies (21/24 studies), positivity in cases was found to be higher than in controls, but odds ratios and confidence intervals were not reported.
The results are controversial. However, they arouse a great interest in the potential participation of HPV in breast carcinogenesis, but rather as an essential cause-effect participant, at least as a co-participant in some cases. The circumstance of HPV positivity in breast cancer can be criticized, but the elements that clearly demonstrate it in a number of cases are also relevant.
尽管人乳头瘤病毒(HPV)与多种癌症的关联已得到充分证实,但HPV是否参与乳腺癌的发生仍存在争议。本研究的目的是全面回顾用于证明人乳腺癌中存在HPV标志物的研究结果和方法,以及这些研究在多大程度上符合证明癌症病毒病因的标准。
我们检索了截至2016年11月发表的将人乳腺癌与HPV相关联的分子研究。
共找到43项原始分子研究,其中一些将病例与非肿瘤对照进行了比较。一些研究未在乳腺组织中检测到HPV,但其他研究检测到HPV的阳性频率不同,在1.2%至86%之间。在大多数病例对照研究(24项研究中的21项)中,病例组的阳性率高于对照组,但未报告优势比和置信区间。
结果存在争议。然而,它们引发了人们对HPV在乳腺癌发生中潜在作用的极大兴趣,但HPV至少在某些情况下更像是一个共同参与者,而非癌症发生的必要因果参与者。乳腺癌中HPV阳性的情况可能受到质疑,但在一些病例中明确证明其存在的因素也具有相关性。